ArticleDermatology and therapy2022

Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study.

Cristina Pellegrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.